Holen Sie sich die Stockscreener-App
32.31
1.20%
0.3843
Handel nachbörslich:
32.27
-0.04
-0.12%
Schlusskurs vom Vortag:
$31.93
Offen:
$31.74
24-Stunden-Volumen:
24,569
Relative Volume:
0.83
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.25%
1M Leistung:
-9.17%
6M Leistung:
+23.92%
1J Leistung:
+27.91%
1-Tages-Spanne:
$31.54
$32.31
1-Wochen-Bereich:
$31.47
$32.75
52-Wochen-Spanne:
$20.01
$37.15
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Firmenname
Roundhill Glp 1 Weight Loss Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
32.31 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.28 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
678.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
681.35 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
267.91 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
607.76 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Aktie (OZEM) Neueste Nachrichten
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
How to Invest in GLP-1 Stocks in 2026 - The Motley Fool
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can You Buy Ozempic Stock in 2025? - The Motley Fool
Best-Performing ETFs of November - TradingView — Track All Markets
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
5 Sector ETFs Up 10% Despite February's Market Slump - MSN
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM - FinancialContent
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? - The Motley Fool
N-PX: Others - 富途牛牛
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - Zacks Investment Research
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
HRTS: Effectively Thinning Investor Portfolios - ETF.com
Finanzdaten der Roundhill Glp 1 Weight Loss Etf-Aktie (OZEM)
Es liegen keine Finanzdaten für Roundhill Glp 1 Weight Loss Etf (OZEM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
Kapitalisierung:
|
Volumen (24h):